Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page
- Check6 days agoChange DetectedAdded How to Read a Study Record, Common Questions, and How to Join a Study to guide users, and adjusted the Intervention/Treatment heading. The page also shows 'No longer looking for participants' to reflect updated recruitment status and includes a version update (Revision: v3.6.0).SummaryDifference0.2%

- Check13 days agoChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, reflecting an updated version of the page metadata.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating a version update to the page rendering. No study details or functionality are modified.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Taiwan site entry was updated from 'Taoyuan, Taiwan, 33305' to 'Taoyuan City, Taiwan, 33305' to reflect the correct administrative designation for the Taoyuan location in the study's locations.SummaryDifference0.0%

- Check57 days agoChange DetectedA site interface revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.